coultreon biopharma
Belgium
series-a
series-a
Stage
1
Investors
About
Coultreon Biopharma develops life-changing medicines for patients affected by chronic inflammatory diseases of high unmet medical needs, focusing on creating oral drugs that modulate the immune system and reduce pro-inflammatory cytokine production, particularly through targeting the SIK3 pathway.
Explore coultreon biopharma's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.